Repeated intratunical injection of adenovirus expressing transforming growth factor-β1 in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie’s disease
- 1 June 2008
- journal article
- Published by Wiley in International Journal of Andrology
- Vol. 31 (3) , 346-353
Abstract
This study was undertaken to establish a Peyronie's disease model with penile curvature by using recombinant transforming growth factor-beta1 (TGF-beta1) protein or adenovirus (ad-TGF-beta1). Four-month-old male Sprague-Dawley rats were divided into seven groups (n = 18 per group): G1 received a single injection of saline into the tunica albuginea (0.1 mL); G2, repeated injections of ad-LacZ (days 0, 3, and 6; 1 x 10(10) particles/0.1 mL respectively); G3, a single injection of recombinant TGF-beta1 protein (700 ng/0.1 mL); G4, repeated injections of recombinant TGF-beta1 protein (days 0, 3 and 6; 700 ng/0.1 mL respectively); G5, a single injection of low-dose ad-TGF-beta1 (1 x 10(10) particles/0.1 mL); G 6, a single injection of high-dose ad-TGF-beta1 (3 x 10(10) particles/0.1 mL); and G7, repeated injections of low-dose ad-TGF-beta1 (days 0, 3, and 6; 1 x 10(10) particles/0.1 mL respectively). Penile curvature was evaluated 30, 45 and 60 days after treatment, and the penis was then harvested for histological examination. Repeated injection of low-dose ad-TGF-beta1 not only induced fibrous scar in the tunica, which lasted up to 60 days after injection, but also resulted in significant penile curvature by artificial erection test 45 days after treatment. A peculiar histological finding in this group was trapping of inflammatory cells in the tunica, subsequent fibrosis, and formation of cartilage and calcification as well as loss of elastin fibres. This model involving repeated injection of ad-TGF-beta1 may contribute to further investigation of the pathogenesis of Peyronie's disease and the development of new therapeutics targeting this pathway.Keywords
This publication has 15 references indexed in Scilit:
- SUBJECTIVE AND OBJECTIVE ANALYSIS OF THE PREVALENCE OF PEYRONIE’S DISEASE IN A POPULATION OF MEN PRESENTING FOR PROSTATE CANCER SCREENINGJournal of Urology, 2004
- Antifibrotic Role of Inducible Nitric Oxide SynthaseNitric Oxide, 2002
- A RAT MODEL OF PEYRONIE’S DISEASE ASSOCIATED WITH A DECREASE IN ERECTILE ACTIVITY AND AN INCREASE IN INDUCIBLE NITRIC OXIDE SYNTHASE PROTEIN EXPRESSIONJournal of Urology, 2000
- Histological and ultrastructural alterations in an animal model of Peyronie’s diseaseBritish Journal of Urology, 1998
- PENILE TRAUMAJournal of Urology, 1997
- PEYRONIE'S DISEASE IS ASSOCIATED WITH AN INCREASE IN TRANSFORMING GROWTH FACTOR-beta PROTEIN EXPRESSIONJournal of Urology, 1997
- Fibrin Deposition in Peyronie's Disease PlaqueJournal of Urology, 1997
- Kollagene und Wachstumsfaktoren in der Heterotopen Ossifikation Erfahrungen mit der nicht radioaktiven in situ Hybridisierung*Der Pathologe, 1994
- The significance of histopathological changes of the normal tunica albuginea in Peyronie's diseaseInternational Urology and Nephrology, 1994
- PEYRONIE'S DISEASE IN ASSOCIATION WITH METOPROLOLThe Lancet, 1977